key: cord-1027335-vprz70q9
authors: Koch, Jana; Uckeley, Zina M; Doldan, Patricio; Stanifer, Megan; Boulant, Steeve; Lozach, Pierre-Yves
title: Host Cell Proteases Drive Early or Late SARS-CoV-2 Penetration
date: 2020-12-23
journal: bioRxiv
DOI: 10.1101/2020.12.22.423906
sha: 1bb916a72527ab8fcfa293c4a68f74576fbcc3b3
doc_id: 1027335
cord_uid: vprz70q9

SARS-CoV-2 is a newly emerged coronavirus (CoV) that spread through human populations worldwide in early 2020. CoVs rely on host cell proteases for activation and infection. The trypsin-like protease TMPRSS2 at the cell surface, cathepsin L in endolysosomes, and furin in the Golgi have all been implicated in the SARS-CoV-2 proteolytic processing. Whether SARS-CoV-2 depends on endocytosis internalization and vacuolar acidification for infectious entry remains unclear. Here, we examined the dynamics of SARS-CoV-2 activation during the cell entry process in tissue culture. Using four cell lines representative of lung, colon, and kidney epithelial tissues, we found that TMPRSS2 determines the SARS-CoV-2 entry pathways. In TMPRSS2-positive cells, infection was sensitive to aprotinin, a TMPRSS2 inhibitor, but not to SB412515, a drug that impairs cathepsin L. Infectious penetration was marginally dependent on endosomal acidification, and the virus passed the protease-sensitive step within 10 min. In a marked contrast, in TMPRSS2-negative cells cathepsin L and low pH were required for SARS-CoV-2 entry. The cathepsin L-activated penetration occurred within 40-60 min after internalization and required intact endolysosomal functions. Importantly, pre-activation of the virus allowed it to bypass the need for endosomal acidification for viral fusion and productive entry. Overall, our results indicate that SARS-CoV-2 shares with other CoVs a strategy of differential use of host cell proteases for activation and infectious penetration. This study also highlights the importance of TMPRSS2 in dictating the entry pathway used by SARS-CoV-2. Significance Preventing SARS-CoV-2 spread requires approaches affecting early virus-host cell interactions before the virus enters and infects target cells. Host cell proteases are critical for coronavirus activation and infectious entry. Here, we reconcile apparent contradictory observations from recent reports on endosomal acidification and the role of furin, TMPRSS2, and cathepsin L in the productive entry and fusion process of SARS-CoV-2. Investigating authentic virus in various cell types, we demonstrated that SARS-CoV-2 developed the ability to use different entry pathways, depending on the proteases expressed by the target cell. Our results have strong implications for future research on the apparent broad tropism of the virus in vivo. This study also provides a handle to develop novel antiviral strategies aiming to block virus entry, as illustrated with the several drugs that we identified to prevent SARS-CoV-2 infection, some with low IC50.

worldwide in early 2020. CoVs rely on host cell proteases for activation and infection. The trypsin-23 like protease TMPRSS2 at the cell surface, cathepsin L in endolysosomes, and furin in the Golgi 24 have all been implicated in the SARS-CoV-2 proteolytic processing. Whether SARS-CoV-2 25 depends on endocytosis internalization and vacuolar acidification for infectious entry remains 26 unclear. Here, we examined the dynamics of SARS-CoV-2 activation during the cell entry process 27 in tissue culture. Using four cell lines representative of lung, colon, and kidney epithelial tissues, 28

we found that TMPRSS2 determines the SARS-CoV-2 entry pathways. In TMPRSS2-positive 29 cells, infection was sensitive to aprotinin, a TMPRSS2 inhibitor, but not to SB412515, a drug that 30 impairs cathepsin L. Infectious penetration was marginally dependent on endosomal acidification, 31 and the virus passed the protease-sensitive step within 10 min. In a marked contrast, in 32 TMPRSS2-negative cells cathepsin L and low pH were required for SARS-CoV-2 entry. The 33 cathepsin L-activated penetration occurred within 40-60 min after internalization and required 34 intact endolysosomal functions. Importantly, pre-activation of the virus allowed it to bypass the 35 need for endosomal acidification for viral fusion and productive entry. Overall, our results indicate 36 that SARS-CoV-2 shares with other CoVs a strategy of differential use of host cell proteases for 37 activation and infectious penetration. This study also highlights the importance of TMPRSS2 in 38 dictating the entry pathway used by SARS-CoV-2. 39 Significance Introduction assays to analyze the SARS-CoV-2 entry process in different epithelial cell types. Using these 104 assays, we determined SARS-CoV-2 dependence on low pH, proteolytic processing, proteases-105 and endosomal acidification-requiring dynamics, endocytosis, and protease-activated membrane 106 fusion. Our work established that SARS-CoV-2 shares with MERS-CoV and other CoVs the ability 107 to make a differential use of host cell proteases to enter and infect target cells. 108 and both the TMPRSS2 and cathepsin L proteases have been implicated in the proteolytic 112 processing of the viral S protein (5, 7, 17, 22, 23). We selected four epithelial cell lines that are 113 known to support SARS-CoV-2 infection, i.e., Calu-3, Caco-2, A549, and Vero cells (7). A549 are 114 intrinsically poorly infectable by SARS-CoV-2 due to the absence of the SARS-CoV-2 receptor 115 ACE2 (7). As such, we used A549 cells stably overexpressing ACE2 (A549*). When cell lysates 116 were subjected to SDS-PAGE and western blotting, we found that TMPRSS2 was effectively 117 expressed in Calu-3 cells and to a lower extent in Caco-2 cells (Fig. 1A) , corroborating results 118 from others (24). Regardless of the presence of TMPRSS2, cathepsin L (from 25 to 31 kDa) and 119 its inactive form, i.e., procathepsin L (35 to 41 kDa), were present in all the cell lines (Fig. 1B) . 120

However, the conversion of procathepsin L to cathepsin L appeared significantly higher in Vero 121 cells than in the three other cell lines. 122

To address how the presence or absence of TMPRSS2 influences the SARS-CoV-2 123 infectious penetration, and how the endosomal acidification contributes to the process, we aimed 124 to compare cell lines expressing or not this protease. To this end, we first defined the timing for a 125 single round of infection using our cell lines. Calu-3 and Caco-2 served as TMPRSS2-positive 126 (TMPRSS2+) cells, and A549* and Vero as non-expressing cells. The susceptibility of Caco-2 and 127

Vero cells to SARS-CoV-2 at multiplicities of infection (MOIs) of 0.1 and 0.5, respectively, was 128 assessed by fluorescence microscopy after immunostaining with a mouse monoclonal antibody 129 (mAb) against the intracellular viral nucleoprotein NP (Fig. 1C) . Results show that 10% of Caco-2 130 cells were positive for NP at 8 hours post-infection (hpi). Similarly, 35% of Vero cells were found 131 infected at 8 hpi (Fig. 1C) . 132

To quantify infection more accurately, we then performed flow cytometry analysis of Caco-133

We next determined the kinetics of the cathepsin L-and TMPRSS2-dependent SARS-CoV-161 2 entry process. Cells were incubated with viruses at a low MOI (~0.9) on ice and rapidly shifted 162 to 37°C to allow virus entry and protease activity. The cathepsin L and TMPRSS2 inhibitors were 163 added at different times after warming to prevent further activation and penetration of the virus. In 

Recent reports indicated that SARS-CoV-2 infection is sensitive to lysosomotropic weak bases 177 that neutralize vacuolar pH such as ammonium chloride (NH4Cl) and chloroquine (7, 10, 11). 178 However, TMPRSS2 is active at the cell surface under neutral pH conditions (20) , unlike cathepsin 179 L, which requires the low-pH environment typical of endolysosomes (21). To assess the 180 importance of endosomal acidification for infectious entry in cells expressing (Caco-2 and Calu-3) 181

and lacking (A549* and Vero) TMPRSS2, cells were exposed to SARS-CoV-2 in the presence of 182 increasing amounts of NH4Cl or chloroquine. Our results showed that both weak bases induced a 183 dose-dependent inhibition of infection regardless of the cell type and of TMPRSS2 expression 184 ( Fig. 3A and 3B) . However, the dose to inhibit 50% of SARS-CoV-2 infection (IC50) was found to 185 be significantly lower in cells devoid of TMPRSS2 compared to cells expressing the protease, 186 reaching a 200-fold difference for chloroquine (Table 1) . 187

To validate the observation that TMPRSS2+ cells were less dependent on endosomal 188 acidification for SARS-CoV-2 infection, we made used of Bafilomycin A1 and Concanamycin B, From these results, it was evident that, similar to the lysosomotropic weak bases, SARS-CoV-2 197 infection appeared to be significantly less sensitive to vATPase inhibitors in TMPRSS2+ cells 198 (Caco-2 and Calu-3) in comparison to cells lacking the protease (Vero and A549* cells) (Table 1) . 199

Our results suggested that SARS-CoV-2 infection relied more on endosomal acidification in cells 201 devoid of TMPRSS2 than cells expressing the protease. To pursue this possibility, we determined 202 the kinetics of the acidification step required for the infectious penetration of SARS-CoV-2 into 203 TMPRSS2-cells. We took advantage of the fact that the neutralization of endosomal pH is nearly 204 instantaneous upon NH4Cl addition to the extracellular medium (27). Virus particles were first 205 allowed to attach to A549* and Vero cells on ice. Entry was then synchronized by switching cells 206 rapidly to 37°C, and NH4Cl was added at different times. In A549* and Vero cells, viruses passed 207 the NH4Cl-sensitive step 15 min after cell warming, and the t1/2 was reached within 50 min (Fig.  208  3E) . Overall, the kinetics of SARS-CoV-2 acid-activated penetration closely resembled the time 209 course of cathepsin L-dependent activation in the absence of TMPRSS2 (Fig. 2C) . 210

In Calu-3 and Caco-2 cells, both of which express TMPRSS2, it was not possible to 211 determine the timing of the acid-requiring step. We failed to detect SARS-CoV-2-infected cells 212 even by adding NH4Cl several hours after transferring the cells from 4 to 37°C (Fig. 3E ). In samples 213

where NH4Cl was omitted, infection was readily detectable with 17% of Calu-3 and Caco-2 cells 214 infected (data not shown) suggesting that the weak base interferes with SARS-CoV-2 replication 215 in these two cell lines. It is highly likely that NH4Cl disrupts TMPRSS2+ cell-specific functions that 216 are important for SARS-CoV-2 replication. NH4Cl not only neutralizes the intracellular pH but also 217 alters all endosomal, lysosomal, and trans-Golgi-network functions that are acid dependent (28). 218

As an alternative method to alter endosomal pH, we used Concanamycin B instead of NH4Cl 219 and added the vATPase inhibitor to Caco-2-cell-bound virus at different times after warming. The 220 time course showed that SARS-CoV-2 infection was insensitive to the Concanamycin B add-in as 221 early as a few seconds after shifting Caco-2 cells to 37°C (Fig. 3F) . In a marked contrast, infectious 222 entry of UUKV started after 15 min and had not reached a maximum 2 h after cell warming. As 223 expected, SARS-CoV-2 passed the Concanamycin B-sensitive step in Vero cells within less than 224 15 min, and infectious entry reached a plateau value after 45 min, somewhat faster than in using 225 NH4Cl (Fig. 3E ). This difference in Vero sensitivity to endosomal pH may be that Concanamycin 226

B not only interferes with endosomal functions that are acid dependent but also indirectly with the 227 maturation of endosomes. However, unlike NH4Cl, it was apparent that Concanamycin B had no 228 adverse effect on SARS-CoV-2 replication in all these experiments. Taken together, these results 229 strongly suggested that SARS-CoV-2 can use two different routes to enter and infect target cells, 230

i.e., fast pH-independent penetration in TMPRSS2+ cells ( Fig. 2D and 3F) and slow acid-activated 231 entry in cells lacking TMPRSS2 ( Fig. 2C and 3E) . CoV-2. 248 LE maturation relies on microtubule-mediated transport to the nuclear periphery and 249 proteasome activity (26, 29). Treatment of Vero cells with colcemid, a drug that interferes with 250 microtubule polymerization, resulted in a 30%-45% decrease in infection (Fig. 4B) . Additionally, 251 late endosomal penetration of IAV and UUKV has been shown to be sensitive to free ubiquitin 252 depletion produced by the proteasome inhibitor MG-132 (26, 30). Therefore, to determine if free 253 ubiquitin was required for SARS-CoV-2 infection, A549* and Vero cells were treated with MG-132. 254

Results show that SARS-CoV-2 infection was strongly inhibited in the presence of MG-132 in both 255 cell lines (Fig. 4C ). The calculated IC50 confirmed the high proficiency (4 to 17 nM) of MG-132 to 256

interfere with the cathepsin L-mediated SARS-CoV-2 entry route (Table 1) . the data suggest that MG-132 impaired viral replication in these assays and not the TMPRSS2-272 dependent SARS-CoV-2 entry process. 273

The penetration of enveloped viruses into the cytosol involves fusion between the viral envelope 275 and a cell membrane. In most cases, endosomal acidification contributes to activate viral 276 glycoproteins and is used as a cue to trigger fusion (12). SARS-CoV-2 does not rely on endosomal 277 acidification to enter TMPRSS2+ cells, which suggests that the virus does not rely on low pH for 278 membrane fusion but solely for the activation of cathepsin L in cells lacking TMPRSS2. 279

To examine the requirement of pH acidification for the SARS-CoV-2 membrane fusion 280 mechanisms, we first assessed the possibility to inactivate the virus with acidic buffers prior 281

infection. In such an assay, the virus undergoes a transition toward the post-fusion state at the 282 optimal pH. If the transition is irreversible, the spike protein is no longer able to fuse with target-283 cell membranes, and thus, the viral particles are rendered non-infectious. With this approach, we 284 found that about 50% of viruses were still infectious in Caco-2 and Vero cells, even after an 285 exposition to buffers at pH ~5 for 10 min (Fig. 5A ). Semliki forest virus (SFV) is an early-penetrating 286 virus that has a Class-II viral fusion glycoprotein with an irreversible priming step triggered at a 287 pH-activation threshold of 6.2 (26). In contrast to SARS-CoV-2, infection by low pH-pretreated 288 SFV was reduced by 70-80% at pH ~6.0 and below (Fig. 5B) . 289

To further investigate the influence of low pH on SARS-CoV-2 fusion, we then evaluated the 290 capacity of SARS-CoV-2 to mediate cell-cell fusion (''fusion-from-within'') as described for 291 unrelated viruses (32). To this end, we used Vero cells as they are negative for TMPRSS2, which 292

makes it a convenient model to monitor proteolytic activation of the S protein at the cell surface 293

CoV-2 for 24 h, and the infected cells were then subjected to buffers of different pH values. The 295 extent of cell-cell fusion, i.e., formation of syncytia, was determined using a fusion index that 296 expresses the average number of fusion events per original mononucleated cell (33). The index 297 reaches 1 when all the nuclei in the microscope field are present in a single cell, and the value is 298 0 when all cells have one nucleus each. Formation of syncytia with two or more nuclei was 299 observed regardless of the pH of the buffer (Fig. 5C ), and the fusion index did not significantly 300 differ when cells were treated with low pH or neutral buffers (Fig. 5D ). Together, our observations 301 strongly suggested that low pH is not required for the SARS-CoV-2 fusion mechanisms. 302

The results suggested that acidification is not required to prompt viral fusion and that proteolytic 304 processing might be sufficient. As furin and TMPRSS2 are believed to mediate the activation of 305 the SARS-CoV-2 spike proteins, we then evaluated the ability of the two proteases to trigger 306 SARS-CoV-2 activation and fusion using our flow cytometry-based infection analysis and syncytia-307 TMPRSS2 at the cell surface as the two enzymes are closely related and both belong to the group 309 of trypsin-like proteases. The use of exogenous cathepsin L was excluded because the enzyme 310 is only active at pH ~5, which would have made it impossible to distinguish between an effect due 311 to low pH or proteolytic cleavage. 312

Viral particles were first subjected to proteases prior to being added to Caco-2 and Vero 313 cells. We found that infection increased as much as 2-to 3-fold following the SARS-CoV-2 314 proteolytic processing by trypsin, whereas the pre-exposure of particles to furin had no apparent 315 effect (Fig. 6A ). Similar results were obtained with our cell-cell fusion assay. Large syncytia with 316 five or more nuclei were observed when infected Vero cells were exposed to trypsin (Fig. 6B) . 317

to the mock-treated samples, for which the only cells with more than one nucleus were those 319 dividing (Fig. 6B) . Additionally, the fusion index in Vero cells was increased under trypsin treatment 320 compared to mock-and furin-treated cells (Fig. 6C ). Altogether our data indicated that proteolytic 321 cleavage is sufficient and necessary for SARS-CoV-2 membrane fusion. 322

Our results support a model where endosomal acidification is not essential for SARS-CoV-2 324 membrane fusion, but SARS-CoV-2 infection relies on low pH for cathepsin L-dependent infection 325 in cells lacking TMPRSS2. Therefore, we tested the possibility that acid pH is required for the 326 activation of endolysosomal proteases that in turn trigger SARS-CoV-2 fusion. In such a scenario, 327 the spike S proteins that are already primed by proteases should no longer rely on low pH for 328 fusion. Indeed, we found that the fusion index was not increased when trypsin treatment was 329 followed by exposure to a decreasing pH of 7.4 to 5 ( Fig. 7A and 7B) , the latter value being typical 330 of the luminal pH of endolysosomes (29). 331 particles were then exposed to buffers at pH ~5 and subsequently subjected to proteolytic 333 cleavage by trypsin. Our results revealed that SARS-CoV-2 infectivity was preserved when viral 334 particles were exposed to the low-pH buffer prior to trypsin treatment in comparison to virus 335 particles that were solely exposed to acidic pH (Fig. 7C) . The infectivity also remained preserved 336 when the virus was first subjected to trypsin and then acidification. Taken together, the results 337

showed that endosomal acidification does not play a role in SARS-CoV-2 membrane fusion, 338 whether it occurs before or after the proteolytic processing of viral particles. In addition, our results 339 strongly suggested that the potential pH-induced conformational changes in the SARS-CoV-2 340 spikes were neither irreversible nor detrimental for the viral fusion. 341

To directly test whether endosomal acidification is needed for the host cell proteases that 342 prime SARS-CoV-2 fusion, and not for the fusion mechanisms themselves, we assessed whether 343 preactivated viral particles no longer depend on endosomal acidification for infectious entry. For 344 this purpose, the proteolytic processing of the virus particles was achieved with trypsin prior to the 345 infection of A549* and Vero cells. To interfere with the acid-dependent endolysosomal proteases, 346

the infection was carried out in the continuous presence of 50 nM of Bafilomycin A1. As A549* 347 and Vero cells do not express TMPRSS2, this assay allowed us to directly test the impact of 348 extracellular protease-activated viral particles. As reported above (Fig. 3C) , infection with 349 untreated viral particles was severely hampered when proton pumps were blocked in the absence 350 of TMPRSS2 (Fig. 7D) . In stark contrast, the protease-preactivated viral particles remained 351 infectious in the presence of Bafilomycin A1 (Fig. 7D) . 352

The capacity of SARS-CoV-2 to infect A549* and Vero cells upon proteolytic activation, 353 despite the absence of functional endolysosomal proteases, was confirmed using NH4Cl. As 354 expected, in our synchronized infection assay, untreated particles became NH4Cl insensitive 50 355 min post entry (Fig. 7E, 7F, and 3E) . However, when the viral particles were pretreated with 356 trypsin, no sensitivity to NH4Cl was observed ( Fig. 7E and 7F) . These results strongly supported 357 the view that, once activated by proteolytic cleavage, the virus is no longer dependent on 358 endosomal acidification for infection. Altogether, our data show that SARS-CoV-2 resembles other 359

CoVs in that its entry depends on diverse host cell proteases. It can use two distinct routes, where 360 either TMPRSS2 mediates its pH-independent penetration from or close to the cell surface or 361 alternatively, it is transported to endolysosomes, where low pH activates cathepsin L that in turn 362 primes viral fusion and penetration. 363 require selective proteases or a coordinated, spatio-temporal combination of several proteases. 367

The importance of endosomal acidification in the productive penetration of all CoVs is also a 368 matter of debate. Furin, TMPRSS2, and cathepsin L have all three been implicated in coronavirus 369 activation for entry (5, 7, 17, 22, 23) , and agents elevating endosomal pH such as chloroquine 370

have been described to interfere with infection (7, 10, 11). SARS-CoV-2 and other CoVs have 371 apparently found a way to use diverse entry mechanisms to infect target cells and spread 372 throughout the host. 373

In this study, we developed reliable and accurate assays to investigate SARS-CoV-2 374 infection in lung, intestine, and kidney epithelial cells, from proteolytic activation to membrane 375 fusion. In agreement with other reports (7, 25), our results showed that SARS-CoV-2 infection was 376 sensitive to inhibitors of TMPRSS2 and cathepsin L. We further found that blocking TMPRSS2 reports that TMPRSS2 processes CoV S and other substrates at or nearby the plasma membrane 395 (39, 40), i.e., at neutral pH. Using aprotinin, we found that half of the bound viral particles required 396 5-10 min to pass the TMPRSS2-dependent step. We cannot completely exclude that aprotinin 397

was not instantaneously effective when it was added to the infected cells. In this case, the timing 398 of TMPRSS2-requiring step was therefore faster. SARS-CoV-2 activation and penetration would 399 then likely take place at the plasma membrane following proteolytic activation, as proposed for EEs, SARS-CoV-2 enters the cytosol of TMRPSS2+ cells, and whether the processing of the S 410 protein is followed by transport of the virus to downstream organelles for penetration. 411

In the absence of TMPRSS2, it was evident that SARS-CoV-2 was dependent on 412 endocytosis and transport through the late endosomal system for infectious penetration. Infectious Our results suggested that the proteolytic activation of the spike S protein was sufficient and 423 necessary for SARS-CoV-2 fusion. The Vero cells used in our virus-mediated cell-cell fusion assay 424 did not express TMPRSS2 on the cell surface. In this assay, exogenous furin failed to promote 425 the syncytia formation, indicating that either furin was inefficient or not sufficient to achieve the full 426 activation of the SARS-CoV-2 protein S at the plasma membrane. The S1/S2 site exhibits a RRAR 427 motif instead the typical RX(R/K)R furin one, and a recent structural study support the view that 428 the cleavage by furin at this site in the S trimers is rather low, about 30% (17, 46, 47). However, 429 we found that, unlike furin, trypsin prompted the formation of syncytia, which rather supports the 430 involvement of proteases in the target cells, such as TMPRSS2 and cathepsin L, to complete the 431 proteolytic processing of the S protein. Others have shown that SARS-CoV-2, and also MERS-432

CoV, mediate cell-cell fusion at neutral pH without any further proteolytic treatment when target 433

It is also apparent from our results that the SARS-CoV-2 progeny was not fully processed 435 and activated. Trypsin pretreatment increased the virus infectivity. More work is evidently required 436 to decipher the SARS-CoV-2 fusion mechanism. The list of the involved host cell proteases is 437 most likely not restricted to TMPRSS2 and cathepsin L, as suggested by a recent biochemistry 438 study (49) . The S proteolytic activation might involve the cleavage of other sites than S1/S2 and 439 S2', similarly to what was found for the MERS-CoV protein S (40). It is, however, tempting to 440 postulate that the cleavage between S1 and S2 is not complete on SARS-CoV-2 particles, with 441 only one or two of the three S1/S2 sites cut by furin within S trimers. In this model, cutting all the 442 S1/S2 sites would be achieved by proteases in target cells such as TMPRSS2 and cathepsin L. 443

The fusogenic conformational change would then occur and be completed by the cleavage of the 444 S2' sites, therefore, unmasking the fusogenic units. The S1/S2 site significantly differs in amino-445 acid residues through CoVs (17) and highly likely influences the overall viral fusion process. 

The mouse mAb against the SARS-CoV nucleoprotein NP (40143-MM05) was purchased from 500

Sino biologicals and used at dilutions of 1:500 for flow cytometry analysis and 1:1,000 for titration 501 in TCID50 assays. The rabbit polyclonal antibody U2 targets all the UUKV structural proteins and 502 was used at a dilution of 1:4,000 for immunohistochemistry (54) . The mouse mAb 8B11A3 against 503 the UUKV nucleoprotein N was a kind gift from Ludwig Institute for Cancer Research (Stockholm, 504 Margaret Kielian (Albert Einstein College of Medicine, USA). mAb 8B11A3 and mAb against SFV 506 E2 were used at a dilution of 1:400 for flow cytometry analysis. The rabbit antibodies against 507 TMPRSS2 (ab92323) and actin (A2066) were obtained from Abcam and Sigma, respectively. The 508 mouse mAb against cathepsin L (BMS1032) and -tubulin (T5158) were bought from Thermo 509

Fisher Scientific and Sigma, respectively. Anti-mouse secondary antibodies were conjugated to 510 Furin and Trypsin were purchased from R&D and Sigma, respectively. Plasmids encoding EGFP-517 tagged Rab7a, Rab7a T22N, and Rab7a Q67L have been described elsewhere (26). 518

Cells were lysed with phosphate buffer saline (PBS) containing 0.1% Triton X-100 (Merck 520 Millipore), according to a standard procedure (54) . Cell lysates were then diluted in LDS sample 521 buffer (Thermo Fisher Scientific) and analyzed by SDS-PAGE (Nu-PAGE Novex 10% Bis-Tris 522 gels; Thermo Fisher Scientific). Proteins were subsequently transferred to polyvinylidene 523 difluoride membranes (iBlot transfer stacks; Thermo Fisher Scientific). The membranes were first 524 blocked with Intercept blocking buffer (LI-COR) and then incubated with primary antibodies against 525 TMPRSS2, cathepsin L, actin, and -tubulin, all diluted in Tris-buffered saline containing 0.1% 526

Tween and Intercept blocking buffer (1:1,000, 1:400, 1:5,000, and 1:2,000, respectively). After 527 extensive washing, the membranes were incubated with the corresponding secondary anti-528 species conjugated to either IRDye 700 and 800CW (both at 1:10,000) or HRP (1:1,000) . Proteins 529

Cells were exposed to viruses at the indicated MOIs in the presence of 2% FBS for 1 h at 37°C. 534

Virus input was then replaced by complete culture medium, and infected cells were incubated for 535 1-piperazineethanesulfonic acid (HEPES) were used as buffers at 100 mM as follow, pH < 5.5, 539 5.5 < pH < 6.5, and 6.5 < pH, respectively. Virus inputs were exposed to buffers at the indicated 540 pH for 10 min at 37°C and then to buffers at neutral pH prior infection. For furin-or trypsin-541 activation, SARS-CoV-2 was pretreated with furin (1 µg.mL -1 ) or trypsin (100 µg.mL -1 ), 542 respectively, for 15 min at 37°C and allowed to infect cells. For inhibition assays, cells were 543 pretreated with drugs for 30 min at 37°C, apart from colcemid pretreatment that lasted 3 h on ice, 544 and then exposed to viruses in the continuous presence of the inhibitors. For inhibitor add-in time 545 courses, virus binding to cells was synchronized on ice for 90 min. Cells were then rapidly warmed 546 to 37°C, and SB412515 (10 µM), aprotinin (30 µM), NH4Cl (at indicated concentrations), 547 

The flow cytometry-based infection assay has been described previously (53). Briefly, infected 566 cells were fixed with 4% formaldehyde for 30 min at RT and permeabilized with 0.1% saponin 567 (Serva). Cells were then exposed to primary antibody at RT for 1 h, washed, and subsequently 568 incubated with secondary anti-mouse antibodies at RT for another 1 h. Infected cells were 569 quantified with a FACSCelesta cytometer (Becton Dickinson) and FlowJo software (TreeStar). 570

As previously reported (58), RNA was harvested from cells using the NuceloSpin RNA extraction 572 kit (Machery-Nagel) according to manufacturer's instructions. The cDNA was synthesized using 573 iSCRIPT reverse transcriptase (BioRad) from 250 ng of total RNA as per supplier 574 recommendations. q-PCR was performed using iTaq SYBR green (BioRad) following the 575 manufacturer's instructions for the SARS-CoV-2 genome using the forward primer, 576 housekeeping gene using the forward primer, CCTGGCGTCGTGATTAGTGAT, and reverse 578 primer, AGACGTTCAGTCCTGTCCATAA. 579

Confluent monolayers of Vero and Caco-2 cells in 96-well plates were infected with 10-fold serial 581 dilutions of SARS-CoV-2. Infected cells were fixed 24 hpi and subjected to immunostaining using 582 the primary mouse mAb anti-SARS-CoV-2 NP and then the secondary anti-mouse antibody 583 800CW (1:10,000). Samples were finally scanned on LI-COR. 584

Infected cells were washed in PBS and treated with DMEM containing 0.2% bovine serum albumin 586 (Gibco) buffered at pH 7.4, 6.0, or 5.0 using 30 mM of HEPES, MES, or citric acid, respectively, 587

for 5 min at 37°C. Alternatively, infected cells were exposed to furin (1 µg.mL -1 ) and trypsin (100 588 µg.mL -1 ) for 5 min at 37°C, and when indicated, followed by acidification of the culture medium as 589 Caco-2 and Vero cells. Infected cells were quantified by flow cytometry as described in Fig. 1D . 

No protease + Trypsin 

Viruses with Single-Stranded, Positive

& Fauci AS (2020) Coronavirus Infections-More Than Just the

The molecular virology of coronaviruses

Isolation and rapid sharing of the 2019 novel coronavirus (SARS-CoV-2) 621 from the first patient diagnosed with COVID-19 in Australia

Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing 623 cells

In situ structural analysis of SARS-CoV-2 spike reveals flexibility 626 mediated by three hinges

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is 628 Blocked by a Clinically Proven Protease Inhibitor

SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and 630 ACE2

Neuropilin-1 is a host factor for SARS-CoV-2 infection

Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and 633 its immune cross-reactivity with SARS-CoV

Remdesivir and chloroquine effectively inhibit the recently emerged 635 novel coronavirus (2019-nCoV) in vitro

Viral membrane fusion

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike

Cryo-EM structure of the 2019-nCoV spike in the prefusion 640 conformation

The SARS-CoV Fusion Peptide 642 Forms an Extended Bipartite Fusion Platform that Perturbs Membrane Order in a Calcium

Syncytia formation by SARS-CoV-2-infected cells

TMPRSS2 and furin are both essential for proteolytic activation of

SARS-CoV-2 in human airway cells

The spike glycoprotein of the new coronavirus 2019-nCoV contains 649 a furin-like cleavage site absent in CoV of the same clade

A Multibasic Cleavage Site in the Spike 651 Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells

Type II transmembrane 654 serine proteases in cancer and viral infections

Cysteine cathepsins: multifunctional enzymes in cancer

Cell entry mechanisms of SARS-CoV-2

Cathepsin L-selective inhibitors: A potentially promising 660 treatment for COVID-19 patients

Data, Reagents, Assays and Merits of Proteomics for SARS

Aprotinin Inhibits SARS-CoV-2 Replication

Entry of bunyaviruses into mammalian cells

Fluorescence probe measurement of the intralysosomal pH in 667 living cells and the perturbation of pH by various agents

Virus entry: what has pH got to do with it?

Late-penetrating viruses. Current opinion in 671 virology

The ubiquitin-vacuolar protein sorting system is 673 selectively required during entry of influenza virus into host cells

Endosome maturation

Preliminary analysis of the requirements for fusion from within 676 and fusion from without by Newcastle disease virus

Cell fusion by Semliki Forest, influenza, and vesicular 679 stomatitis viruses

The tetraspanin CD9 facilitates MERS-coronavirus entry by 681 scaffolding host cell receptors and proteases

Tetraspanins: Architects of Viral Entry 683 and Exit Platforms

TMPRSS2 activates the human coronavirus 229E for cathepsin-685 independent host cell entry and is expressed in viral target cells in the respiratory epithelium

Functional analysis of 694 potential cleavage sites in the MERS-coronavirus spike protein

Role of the spike glycoprotein of human Middle

East respiratory syndrome coronavirus (MERS-CoV) in virus entry and syncytia formation

Similar uptake but different trafficking and escape routes of reovirus 699 virions and infectious subvirion particles imaged in polarized Madin-Darby canine kidney cells

The ubiquitin-proteasome system facilitates the transfer of murine 702 coronavirus from endosome to cytoplasm during virus entry

Inhibitors of cathepsin L prevent severe acute respiratory syndrome 704 coronavirus entry

Protease-mediated entry via the 707 endosome of human coronavirus 229E

SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform 709 on virus evolution and furin-cleavage effects

Distinct conformational states of SARS-CoV-2 spike protein

Middle East respiratory syndrome coronavirus 713 infection mediated by the transmembrane serine protease TMPRSS2

Structural modeling of 2019-novel

coronavirus (nCoV) spike protein reveals a proteolytically-sensitive activation loop as a 717 distinguishing feature compared to SARS-CoV and related SARS-like coronaviruses

Protease inhibitors targeting coronavirus and filovirus entry

Cryo-EM Structures of SARS-CoV-2 Spike without and with ACE2

Reveal a pH-Dependent Switch to Mediate Endosomal Positioning of Receptor-Binding

On the entry of Semliki forest virus into

BHK-21 cells

Uukuniemi Virus as a Tick-Borne Virus Model

DC-SIGN as a receptor for phleboviruses

Formation and intracellular transport of a heterodimeric 730 viral spike protein complex

Genome-wide small interfering RNA screens reveal VAMP3 as a novel 732 host factor required for Uukuniemi virus late penetration

NSs amyloid formation is associated with the virulence of Rift Valley 734 fever virus in mice

Novel Toscana Virus Reverse Genetics System Establishes NSs as an 736 Antagonist of Type I Interferon Responses

ACE2-expressing A549 cells. (C) Vero and Caco-2 cells were infected with SARS-CoV-2

Nuclei were stained 743 with DAPI (blue) before imaging by fluorescence wide-field microscopy. (D) Vero and Caco-2 cells 744 were exposed to SARS-CoV-2 at a MOI of 0

After fixation and permeabilization, infected cells were stained with the primary mAb against NP

Infection was analyzed by flow cytometry. SSC-A, side scatter, area. (E) Infection of Vero and 747

Caco-2 cells was monitored over 24 h using the flow cytometry-based assay used for the 748 experiment shown in panel D. Infection is given as the total fluorescence associated with the NP 749 protein-positive cells. MFI, mean of fluorescence intensity. (F) SARS-CoV-2 mRNA levels were 750 quantified by qRT-PCR in both Vero and Caco-2 cells infected at MOIs of 0.5 and 0.1, respectively, 751 for up to 24 h. (G) Supernatants from infected cells were collected during the time course in F

SARS-CoV-2 makes a differential use of host cell proteases for infectious 755 penetration. (A and B) Cells were pre-treated at indicated concentrations of aprotinin (A)

SB412515 (B), which are inhibitors of TMPRSS2 and cathepsin L, respectively. Infection with

Infected cells were 758 quantified by flow cytometry as described in Fig. 1D, and data normalized to samples where 759 inhibitors had been omitted. (C and D) SARS-CoV-2 particles (MOI of 0.9) were bound to A549* 760 and Vero cells (C) or Calu-3 and Caco-2 cells (D) on ice for 90 min, and subsequently, warmed 761 rapidly to 37°C to allow infectious penetration. 10 µM of SB412515 (C) or 30 µM of aprotinin (D) 762 infected with SARS-CoV-2 in the continuous presence of drug

Infected cells were quantified by flow cytometry as 769 described in Fig. 1D, and data normalized to samples where inhibitors had been omitted

Subsequently, cells were 771 rapidly shifted to 37°C to allow penetration. NH4Cl (50 mM for A549* and Vero cells, and 75 mM 772 for Calu-3 and Caco-2 cells) was added at indicated times to neutralize endosomal pH and block 773 the acid-dependent step of SARS-CoV-2 infectious penetration. Infected cells were analyzed by 774 flow cytometry, and data normalized to samples where NH4Cl had been omitted. (F) Same than 775 in (E) but using Concanamycin B (50 nM)

SARS-CoV-2 relies on late endosomal maturation for infection. (A) EGFP-Rab7a wild-778 type (wt), Q79L (constitutively active mutant), and T22N (dominant-negative mutant) were 779 transiently expressed in Vero cells. The cells were then infected with SARS-CoV-2 at a MOI

Using flow cytometry, cell populations were selected for levels of EGFP-Rab7a expression 781 in roughly one-log increments, and infected cells were quantified within each population 8 hpi

Data were normalized to infection in cell populations with the lowest EGFP-Rab7a intensity

Unpaired t-test with Welch's correction was applied

784 and C) Cells were pre-treated with colcemid (B) and MG-132 (C) at indicated concentrations and 785 subsequently infected with SARS-CoV-2 in the continuous presence of inhibitors